VIRP Stock Overview
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for VIRP from our risk checks.
Virbac SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €357.00 |
| 52 Week High | €377.50 |
| 52 Week Low | €232.50 |
| Beta | 0.91 |
| 1 Month Change | 3.33% |
| 3 Month Change | 5.93% |
| 1 Year Change | 17.82% |
| 3 Year Change | 27.96% |
| 5 Year Change | 125.38% |
| Change since IPO | 2,805.27% |
Recent News & Updates
Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results
Mar 22
Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?
Jan 18Recent updates
Here's What Analysts Are Forecasting For Virbac SA (EPA:VIRP) After Its Yearly Results
Mar 22Is Virbac SA (EPA:VIRP) Trading At A 23% Discount?
Jan 18Virbac SA's (EPA:VIRP) Shares Climb 25% But Its Business Is Yet to Catch Up
Dec 27Virbac (EPA:VIRP) Has A Pretty Healthy Balance Sheet
Oct 19Is There An Opportunity With Virbac SA's (EPA:VIRP) 40% Undervaluation?
Sep 26Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching
Sep 05A Look At The Fair Value Of Virbac SA (EPA:VIRP)
Jun 20Does Virbac (EPA:VIRP) Deserve A Spot On Your Watchlist?
May 31Is Virbac (EPA:VIRP) Using Too Much Debt?
Apr 09Are Investors Undervaluing Virbac SA (EPA:VIRP) By 34%?
Feb 28Virbac SA (EPA:VIRP) Shares Could Be 50% Below Their Intrinsic Value Estimate
Nov 25Does Virbac (EPA:VIRP) Have A Healthy Balance Sheet?
Oct 14An Intrinsic Calculation For Virbac SA (EPA:VIRP) Suggests It's 42% Undervalued
Aug 07These 4 Measures Indicate That Virbac (EPA:VIRP) Is Using Debt Safely
Jun 26Virbac SA (EPA:VIRP) Shares Could Be 38% Below Their Intrinsic Value Estimate
May 01We Think Virbac (EPA:VIRP) Can Manage Its Debt With Ease
Mar 26Virbac SA (EPA:VIRP) Shares Could Be 36% Below Their Intrinsic Value Estimate
Jan 26Here's Why I Think Virbac (EPA:VIRP) Is An Interesting Stock
Dec 28A Look At The Fair Value Of Virbac SA (EPA:VIRP)
Oct 27Is Virbac (EPA:VIRP) Using Too Much Debt?
Oct 12Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today
Sep 26Is Virbac SA (EPA:VIRP) Trading At A 22% Discount?
Jul 15Is Now The Time To Put Virbac (EPA:VIRP) On Your Watchlist?
Jun 27Is Virbac (EPA:VIRP) A Risky Investment?
May 27Robust Earnings May Not Tell The Whole Story For Virbac (EPA:VIRP)
Mar 24Are Investors Undervaluing Virbac SA (EPA:VIRP) By 32%?
Mar 12Here's Why We Think Virbac (EPA:VIRP) Is Well Worth Watching
Feb 22Is Virbac SA (EPA:VIRP) Popular Amongst Insiders?
Feb 03
Virbac SA's (EPA:VIRP) Stock Is Going Strong: Is the Market Following Fundamentals?
Jan 05Does Virbac's (EPA:VIRP) Share Price Gain of 96% Match Its Business Performance?
Dec 18Estimating The Fair Value Of Virbac SA (EPA:VIRP)
Dec 01Here's Why I Think Virbac (EPA:VIRP) Might Deserve Your Attention Today
Nov 18Shareholder Returns
| VIRP | FR Pharmaceuticals | FR Market | |
|---|---|---|---|
| 7D | -0.8% | -0.5% | -0.1% |
| 1Y | 17.8% | -14.0% | 1.3% |
Return vs Industry: VIRP exceeded the French Pharmaceuticals industry which returned -14% over the past year.
Return vs Market: VIRP exceeded the French Market which returned 1.3% over the past year.
Price Volatility
| VIRP volatility | |
|---|---|
| VIRP Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 3.5% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.5% |
| 10% least volatile stocks in FR Market | 2.3% |
Stable Share Price: VIRP has not had significant price volatility in the past 3 months.
Volatility Over Time: VIRP's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1968 | 5,459 | Sebastien Huron | corporate.virbac.com |
Virbac SA manufactures and sells a range of products and services for companion animals and farm animals in France, Europe, Latin America, North America, Asia, Pacific, and Africa and the Middle East. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners.
Virbac SA Fundamentals Summary
| VIRP fundamental statistics | |
|---|---|
| Market cap | €2.99b |
| Earnings (TTM) | €121.30m |
| Revenue (TTM) | €1.25b |
24.6x
P/E Ratio2.4x
P/S RatioIs VIRP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VIRP income statement (TTM) | |
|---|---|
| Revenue | €1.25b |
| Cost of Revenue | €433.87m |
| Gross Profit | €813.03m |
| Other Expenses | €691.73m |
| Earnings | €121.30m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Sep 13, 2024
| Earnings per share (EPS) | 14.49 |
| Gross Margin | 65.20% |
| Net Profit Margin | 9.73% |
| Debt/Equity Ratio | 9.6% |
How did VIRP perform over the long term?
See historical performance and comparison